Metformin Improves the Hepatic Steatosis Index in Non-Obese Patients with Polycystic Ovary Syndrome

Non-alcoholic fatty liver disease (NAFLD) is a common yet little recognized health problem in women with polycystic ovary syndrome (PCOS). In a retrospective setting, we investigated the effects of metformin treatment on the hepatic steatosis index (HSI) as a readily available biomarker panel for NA...

Descripción completa

Detalles Bibliográficos
Autores principales: Riemann, Annika, Blaschke, Martina, Jauho-Ghadimi, Annukka, Siggelkow, Heide, Gollisch, Katja Susanne Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331742/
https://www.ncbi.nlm.nih.gov/pubmed/35893386
http://dx.doi.org/10.3390/jcm11154294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331742/
https://www.ncbi.nlm.nih.gov/pubmed/35893386
http://dx.doi.org/10.3390/jcm11154294

Ejemplares similares